Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03257436 · ClinicalTrials.gov registry record · NA
Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)
A NA study, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- NA
- Development phase
- 586
- Enrollment target
NCT03257436: Completed NA study, sponsored by Boston Scientific Corporation.
NCT03257436 is a NA study that has completed, run by Boston Scientific Corporation. The registered enrollment target is 586 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (58% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03257436, a NA study, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 586 participants
- Enrollment target
Study Summary
Prospective, multi-center, single arm, post approval study to be conducted in the United States.
Primary Outcome
Proportion of subjects free from LVMSP feature related complications at 12 months
Interventions
- DEVICE CRT-D
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 586 participants |
| Start Date | 2018-01-05 |
| Est. Completion | 2020-11-19 |
| Phase | NA |
What the finished NCT03257436 record still lists
NCT03257436 is an interventional study that assigns participants to a tested intervention. The registered 586 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (58% lower).
The record links to 0 conditions, and to 1 intervention - of which CRT-D is the first listed.
NCT03257436 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03257436 about?
NCT03257436 is a clinical study titled "Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)". Prospective, multi-center, single arm, post approval study to be conducted in the United States.
What is the current status of trial NCT03257436?
This trial is currently completed. It is a NA study. The enrollment target is 586 participants. The study started on 2018-01-05. Estimated completion is 2020-11-19.
What interventions are being tested in trial NCT03257436?
The interventions under investigation include: CRT-D (DEVICE).
Who is sponsoring clinical trial NCT03257436?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03257436's enrollment target sits among peer trials
586 176th of 2000 higher than 1,825 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04134260 · 586 participants · Phase 3
Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial
- NCT06100770 · 586 participants
Aveir AR Coverage With Evidence Development (CED) Study
- NCT06183281 · 586 participants · NA
Integrating Nonpharmacologic Strategies for Pain With Inclusion, Respect, and Equity
- NCT06976203 · 586 participants · Phase 3
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI